High-throughput synapse-resolving two-photon fluorescence microendoscopy for deep-brain volumetric imaging in vivo

  1. Guanghan Meng
  2. Yajie Liang
  3. Sarah Sarsfield
  4. Wan-chen Jiang
  5. Rongwen Lu
  6. Joshua Tate Dudman
  7. Yeka Aponte
  8. Na Ji  Is a corresponding author
  1. University of California, Berkeley, United States
  2. Janelia Research Campus, Howard Hughes Medical Institute, United States
  3. National Institute on Drug Abuse, United States
  4. Johns Hopkins University School of Medicine, United States

Abstract

Optical imaging has become a powerful tool for studying brains in vivo. The opacity of adult brains makes microendoscopy, with an optical probe such as a gradient index (GRIN) lens embedded into brain tissue to provide optical relay, the method of choice for imaging neurons and neural activity in deeply buried brain structures. Incorporating a Bessel focus scanning module into two-photon fluorescence microendoscopy, we extended the excitation focus axially and improved its lateral resolution. Scanning the Bessel focus in 2D, we imaged volumes of neurons at high-throughput while resolving fine structures such as synaptic terminals. We applied this approach to the volumetric anatomical imaging of dendritic spines and axonal boutons in the mouse hippocampus, and functional imaging of GABAergic neurons in the mouse lateral hypothalamus in vivo.

Data availability

Almost all data needed to evaluate the conclusions in the paper are present in the paper or the supplementary materials; Raw image data for Figs. 2, 4 & 9 are available from Dryad, 10.5061/dryad.pr4t978

The following data sets were generated

Article and author information

Author details

  1. Guanghan Meng

    Department of Physics, University of California, Berkeley, Berkeley, United States
    Competing interests
    No competing interests declared.
  2. Yajie Liang

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    No competing interests declared.
  3. Sarah Sarsfield

    Neuronal Circuits and Behavior Unit, National Institute on Drug Abuse, Baltimore, United States
    Competing interests
    No competing interests declared.
  4. Wan-chen Jiang

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    No competing interests declared.
  5. Rongwen Lu

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    Rongwen Lu, The Bessel focus scanning intellectual property has been licensed to Thorlabs, Inc. by HHMI.
  6. Joshua Tate Dudman

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4436-1057
  7. Yeka Aponte

    Solomon H Snyder Department of Neuroscience, Johns Hopkins University School of Medicine, Baltimore, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5967-2579
  8. Na Ji

    Department of Physics, University of California, Berkeley, Berkeley, United States
    For correspondence
    jina@berkeley.edu
    Competing interests
    Na Ji, The Bessel focus scanning intellectual property has been licensed to Thorlabs, Inc. by HHMI.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5527-1663

Funding

Howard Hughes Medical Institute

  • Guanghan Meng
  • Yajie Liang
  • Wan-chen Jiang
  • Rongwen Lu
  • Joshua Tate Dudman
  • Na Ji

National Institute of Neurological Disorders and Stroke

  • Guanghan Meng
  • Na Ji

National Institute on Drug Abuse

  • Sarah Sarsfield
  • Yeka Aponte

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. David Kleinfeld, University of California, San Diego, United States

Ethics

Animal experimentation: All animal experiments were conducted according to the United States National Institutes of Health guidelines for animal research. Procedures and protocols were approved by the Institutional Animal Care and Use Committee at Janelia Research Campus, Howard Hughes Medical Institute (protocol number: 16-147)

Version history

  1. Received: August 5, 2018
  2. Accepted: December 20, 2018
  3. Accepted Manuscript published: January 3, 2019 (version 1)
  4. Accepted Manuscript updated: January 4, 2019 (version 2)
  5. Version of Record published: January 18, 2019 (version 3)

Copyright

© 2019, Meng et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 11,124
    Page views
  • 1,575
    Downloads
  • 69
    Citations

Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Guanghan Meng
  2. Yajie Liang
  3. Sarah Sarsfield
  4. Wan-chen Jiang
  5. Rongwen Lu
  6. Joshua Tate Dudman
  7. Yeka Aponte
  8. Na Ji
(2019)
High-throughput synapse-resolving two-photon fluorescence microendoscopy for deep-brain volumetric imaging in vivo
eLife 8:e40805.
https://doi.org/10.7554/eLife.40805

Share this article

https://doi.org/10.7554/eLife.40805

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.